Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Penumbra, Inc.

Penumbra Inc is a global healthcare company focused on innovating novel technologies to assist in the treatment of various medical conditions.

Metric
Company Name	Penumbra, Inc.
Symbol	PEN
MSH ID	COM:PENUMBRAINC
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	US
Stage
Employee Count	4.20K
Website	penumbrainc.com
LinkedIn
Founders

Metric
Market Cap	6.96B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	1.06B
Revenue (LTM)
Revenue (NTM)
Gross Profit	682.64M
EBITDA	126.86M
Operating Income	73.55M
Net Income	90.95M
EPS	2.37
Diluted EPS	2.32
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.65
Operating Profit Margin	0.07
EBITDA Margin	0.12
Net Profit Margin	0.09
Return on Equity	0.08
Return on Assets	0.06
Return on Capital Employed	0.05

COM:PENUMBRAINC

Penumbra Inc

Last Close

240.49

22/11 21:00

Market Cap

6.96B

Beta: -

Volume Today

251.99K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	240.63
P/B Ratio	8.85
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	8.12
EV Multiple	253.62

Metric
Days Sales Outstanding	75.79
Days Payables Outstanding	28.31
Days Inventory Outstanding	379.58
Operating Cycle	446.37
Cash Conversion Cycle	420.00
Asset Turnover	0.74

Metric
Operating Cash Flow	97.33M
Free Cash Flow	82.12M
Cash Flow to Debt	0.56
Operating Cash Flow/Sales	0.11
Free Cash Flow Yield	0.00

Metric
Cash & Equivalents	167.49M
Accounts Receivable	-266K
Inventory	388.02M
Goodwill	166.27M
Debt to Capitalization	0.17
Debt to Assets	0.16
Current Ratio	5.99
Quick Ratio	3.77

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.05
R&D to Revenue	0.08
SG&A to Revenue